SPRD/Ztm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 25 |
0.72 |
cm/week |
0.04 |
0.2 |
unspecified method |
0 |
DMBA oral gavage |
0 |
the first 3 weeks of tumor growth |
11509 |
74 |
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
107 days-128 days |
14 |
0.62 |
cm/week |
0.02 |
0.08 |
unspecified method |
0.0 |
DMBA oral gavage |
0 |
the first 3 weeks of tumor growth |
11347 |
73 |
SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 33 |
0.53 |
cm/week |
0.02 |
0.11 |
unspecified method |
0 |
DMBA oral gavage |
0 |
the first 3 weeks of tumor growth |
11512 |
74 |
SPRD/Ztm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
97 days-118 days |
48 |
0.7 |
cm/week |
0.0 |
0.03 |
unspecified method |
0.0 |
DMBA oral gavage |
0 |
the first 3 weeks of tumor growth |
11346 |
73 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 52 |
0.73 |
cm/week |
0.03 |
0.22 |
unspecified method |
0 |
DMBA oral gavage |
0 |
the first 3 weeks of tumor growth |
11511 |
74 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
99 days-120 days |
46 |
0.79 |
cm/week |
0.01 |
0.05 |
unspecified method |
0.0 |
DMBA oral gavage |
0 |
the first 3 weeks of tumor growth |
11348 |
73 |
SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 36 |
0.37 |
cm/week |
0.03 |
0.18 |
unspecified method |
0 |
DMBA oral gavage |
0 |
the first 3 weeks of tumor growth |
11349 |
74 |
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 16 |
0.65 |
cm/week |
0.08 |
0.32 |
unspecified method |
0 |
DMBA oral gavage |
0 |
the first 3 weeks of tumor growth |
11510 |
74 |